KO EN

Video Script

Global Bio Conference 2023

Full script and on-screen information from "Global Bio Conference 2023" (2023), an on-site event coverage for Korea Biomedicine Industry Association. Produced by greatminds.

Client
Korea Biomedicine Industry Association
Year
2023
Format
On-site Event Coverage
On YouTube
Watch ↗
Production
greatminds

View the project →

Chapters

  1. Opening of GBC 2023 and Key Metrics

    The opening of GBC 2023 highlights key metrics, including 5,034 attendees from 21 countries, 89 lectures by 85 speakers, and 29 cases of 1:1 meetings with national regulators across 8 countries and 14 companies.

  2. Plenary Sessions, Specialized Forums, and Workshops

    Keynote and plenary sessions featuring speakers from WHO, Roche, Duke-NUS Medical School, and CEPI take place alongside specialized forums on vaccines, GMP, recombinant protein products, and regulatory science.

  3. Global Expert Interviews and Closing

    Experts from global regulatory bodies and pharmaceutical companies share reflections on the success of the conference and emphasize the importance of international collaboration before the event concludes.

Key facts from the film

  1. GBC 2023 gathered 5,034 attendees from 21 countries.

  2. At GBC 2023, 85 speakers delivered a total of 89 lectures.

  3. A total of 29 cases of 1:1 meetings with national regulators took place, joining 8 countries and 14 companies.

  4. Ali M. Alsamil expressed gratitude to MFDS colleagues for the invitation.

    “Thank you so much to our colleagues at MFDS for inviting us” — Ali M. Alsamil

  5. Lyne Le Palaire stated that GBC is a well-organized conference providing the opportunity to meet authorities and share experiences.

    “The GBC conference actually is a very well organized conference that gives the opportunity to meet with the authorities to share experience” — Lyne Le Palaire

  6. Hye-Na Kang noted that GBC was a great success this year and expressed confidence that it will achieve even more next year.

    “Looking back upon how great GBC has been so far, this year was such a success, and i am sure GBC will achieve so much more next year as well, 그게 일단 기회가 되고,” — Hye-Na Kang

  7. John CW Lim hoped for a strong commitment to collaboration and collective effort among all stakeholders by the end of the conference.

    “My hope is at the end of the conference there will be a strong commitment to collaborations and for all the stakeholders to work together” — John CW Lim

  8. Stefan Frings emphasized that academia, industry, regulatory authorities, and global bodies like WHO must work together.

    “We have to collaborate. Academia, Industry, Regulatory authorities, and yes, this is an Asian and Global body like WHO. We have to work together” — Stefan Frings

FAQ

What is the Global Bio Conference 2023 film?

It is a 3:18 highlight film of the three days of the Global Bio Conference 2023 (GBC 2023), hosted by Korea's Ministry of Food and Drug Safety and organised by the Korea Biomedicine Industry Association. It moves from headline figures such as attendance, through keynotes and specialist forums and workshops, to interviews with participants from overseas regulators, international bodies, pharmaceutical companies and academia. greatminds handled multi-camera filming, on-site editing and post-production in 2023. The project page also carries a 21-second film announcing the event's dates, venue and theme.

When and where was GBC 2023 held, and what was its theme?

It ran from 30 August to 1 September 2023 at the Grand InterContinental Seoul Parnas under the theme "Bio Future: Innovation & Collaboration", as shown on the film's closing card.

How large was GBC 2023?

The opening shows 5,034 attendees from 21 countries and 89 lectures by 85 speakers. One-to-one meetings with national regulators numbered 29, involving 8 countries and 14 companies: Brazil, Colombia, Ecuador, Japan, the Philippines, Saudi Arabia, the United States and Vietnam.

Who hosted and organised GBC 2023?

It was hosted by the Ministry of Food and Drug Safety (MFDS) and organised by the Korea Biomedicine Industry Association (KoBIA), as credited near the end of the film.

What did participants say in the interviews?

Ali M. Alsamil of the Saudi FDA and Caren Mangorangca of FDA Philippines thanked MFDS and the organising committee. Lyne Le Palaire of Sanofi called GBC a very well-organised conference that offers the chance to meet authorities and share experience, and Hye-Na Kang of WHO said that after such a successful year she looked forward to even more next year. John CW Lim of Duke-NUS Medical School and Stefan Frings of Roche stressed that academia, industry, regulators and international bodies must work together.

How did greatminds cover a three-day event?

Eighteen programmes and 89 lectures ran in parallel over three days, with a limited crew. Key sessions were prioritised with the organisers in advance and teams deployed accordingly, and a mobile editing setup on site turned footage into highlight clips right after each shoot. The result was a full highlight film alongside individual session videos.

Speakers

  • Ali M. AlsamilSaudi FDA
  • Lyne Le PalaireSanofi
  • Hye-Na KangWHO
  • Caren MangorangcaFDA Philippines
  • John CW LimDuke-NUS Medical School
  • Stefan FringsRoche

Full transcript

  1. Ali M. Alsamil

    Thank you so much to our colleagues at MFDS for inviting us.

    초청해 주신 식약처(MFDS) 동료 여러분께 진심으로 감사드립니다.

  2. Lyne Le Palaire

    The GBC conference actually is a very well organized conference that gives the opportunity to meet with the authorities to share experience.

    GBC는 규제 당국과 만나 경험을 나눌 기회를 주는, 정말 잘 조직된 컨퍼런스입니다.

  3. Hye-Na Kang

    Looking back upon how great GBC has been so far, this year was such a success, and I am sure GBC will achieve so much more next year as well.

    GBC가 발전해 온 걸 보면, 내년에는 올해보다… 정말 올해 만점인데 얼마나 더 잘할 수 있을까, 그게 일단 기대가 되고요.

  4. Caren Mangorangca

    Thank you very much for the MFDS and other organizing committees. Gamsahamnida.

    식약처(MFDS)와 조직위원회 여러분께 진심으로 감사드립니다. 감사합니다.

  5. John CW Lim

    My hope is at the end of the conference there will be a strong commitment to collaborations and for all the stakeholders to work together.

    컨퍼런스가 끝날 때 협력을 향한 굳은 약속이 생기고, 모든 이해관계자가 함께 일하게 되기를 바랍니다.

  6. Stefan Frings

    We have to collaborate. Academia, industry, regulatory authorities, and yes, this is an Asian and global body like WHO. We have to work together.

    우리는 협력해야 합니다. 학계와 산업계, 규제 당국, 그리고 WHO 같은 아시아·세계 기구가 함께 일해야 합니다.

On-screen information

Text shown on screen as graphics — captions, figures and place names — in order of appearance.

  1. GBC 2023 Global Bio Conference

  2. 5,034 ATTENDEES FROM 21 COUNTRIES

  3. 89 LECTURES BY 85 SPEAKERS

  4. 1:1 MEETING WITH NATIONAL REGULATORS A TOTAL OF 29 CASES JOINING 8 COUNTRIES AND 14 COMPANIES Brazil Colombia Ecuador Japan Philippines Saudi Arabia USA Vietnam

  5. ENJOYING A VARIETY OF BIOPHARMACEUTICAL FIELDS BIO BOOTH EXHIBITION

  6. Keynote & PlenarySession Yukiko Nakatani, WHO

  7. Keynote & PlenarySession Stefan Frings, Roche

  8. Keynote & PlenarySession John CW Lim, Duke-NUS Medical School

  9. Keynote & PlenarySession Richard Hatchett, CEPI

  10. Vaccine Forum Adam Hacker / Jinho Shin / Marco Cavaleri / Hiti Silo / Jin S. Park

  11. GMP Forum Bob McDowall / Jason Cheung / Joonkyu Park

  12. Recombinant Protein Products Forum Hye-Na Kang / Kenji Hayamizu / John Lambert / Sangsoon Yoon / Eun Young Park

  13. Workshop on Animal Testing Alternatives for Biologicals Pradip Das / Richard Isbrucker / Koji Ishii / Eliot Lilley / Jong-Won Kim / Chulhyun Lee / So Young Yune

  14. Blood Product & Vaccine Accessibility Forum Yuyun Siti Maryuningsih / Jicui Dong / Jeeho Heo / Lyne Le Palaire

  15. Regulatory Workshop Gi Hyun Kim / Milton Eduardo Zambrano Masache / Atsushi Nishikawa / Jun Park / Dung Luu Thi / Mariela Pardo Corredor / Luis Guillermo Restrepo Velez / Ali Alsamil

  16. Advanced Biopharmaceuticals Policy and Quality Forum Youngmi Ji / Abdulaziz A. Alsayyari / Hyun Ok Kim / Kaku Saito / Samson Ng

  17. Regulatory Science Forum Tina Morrison / Yoshiaki Uyama / John CW Lim / Sally Choe / Youngju Choi

  18. Biodigital Convergence Innovation Technology Forum Bart Spee / Myung Jin Son / Uwe Marx / Sun Kim / Daehee Lee / Hyunil Kim

  19. Innovative Medical Devices Forum Jonghyun Kim / Eun-ha Choi / Chan Yo Won / In cheol Jeong / Seong Ji Kang / Hyun Seung Yu / Seungyong Lee

  20. Nanomedicines Forum Anil K. Patri / Marina Dobrovolskaia / Paolo Decuzzi / Kumiko Sakai-Kato / Cheolhee Won / Min Beom Heo / Won-Im Do

  21. Mentoring for Bio Youth Younghye Chi / Jongbum Jeon / Junhyuk Lee / Dahee Choi / Inyoung Hwang

  22. The 6th NIFDS-PMDA Joint Workshop

  23. Recombinant Protein Products Reviewer Workshop

  24. Asian National Control Laboratory Network Meeting

  25. Policy Discussion on Patient-Centered Pharmaceutical Safety Management

  26. Host Ministry of Food and Drug Safety, MFDS

  27. Organizer Korea Biomedicine Industry Association, KoBIA

  28. Special Thanks to The Republic of Korea Health & Welfare Committee Dongkun Shin

  29. Special Thanks to The Republic of Korea Health & Welfare Committee Jonghean Baek

    Special Thanks to Korea Pharmaceutical and Bio-Pharma Manufactures Association Yunhong Noh

  30. Saudi FDA Ali M. Alsamil

  31. Sanofi Lyne Le Palaire

  32. WHO Hye-Na Kang

  33. FDA Philippines Caren Mangorangca

  34. Duke-NUS Medical School John CW Lim

  35. Roche Stefan Frings

  36. See you at GBC 2024!

  37. Global Bio Conference 2023 Bio Future: Innovation & Collaboration Aug. 30 - Sep. 1

    Grand InterContinental Seoul Parnas